245 related articles for article (PubMed ID: 36920494)
1. The diagnostic performance of functional dopaminergic scintigraphic imaging in the diagnosis of dementia with Lewy bodies: an updated systematic review.
Jreige M; Kurian GK; Perriraz J; Potheegadoo J; Bernasconi F; Stampacchia S; Blanke O; Alessandra G; Lejay N; Chiabotti PS; Rouaud O; Nicod Lalonde M; Schaefer N; Treglia G; Allali G; Prior JO
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):1988-2035. PubMed ID: 36920494
[TBL] [Abstract][Full Text] [Related]
2. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.
McCleery J; Morgan S; Bradley KM; Noel-Storr AH; Ansorge O; Hyde C
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010633. PubMed ID: 25632881
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.
McKeith I; O'Brien J; Walker Z; Tatsch K; Booij J; Darcourt J; Padovani A; Giubbini R; Bonuccelli U; Volterrani D; Holmes C; Kemp P; Tabet N; Meyer I; Reininger C;
Lancet Neurol; 2007 Apr; 6(4):305-13. PubMed ID: 17362834
[TBL] [Abstract][Full Text] [Related]
4. 123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias.
Brigo F; Turri G; Tinazzi M
J Neurol Sci; 2015 Dec; 359(1-2):161-71. PubMed ID: 26671107
[TBL] [Abstract][Full Text] [Related]
5. A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.
Colloby SJ; Firbank MJ; Pakrasi S; Lloyd JJ; Driver I; McKeith IG; Williams ED; O'Brien JT
Int Psychogeriatr; 2008 Dec; 20(6):1124-40. PubMed ID: 18752700
[TBL] [Abstract][Full Text] [Related]
6. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.
Walker Z; Jaros E; Walker RW; Lee L; Costa DC; Livingston G; Ince PG; Perry R; McKeith I; Katona CL
J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1176-81. PubMed ID: 17353255
[TBL] [Abstract][Full Text] [Related]
7. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
[TBL] [Abstract][Full Text] [Related]
8. [The applicability of 123I-FP-CIT SPECT dopamine transporter imaging in clinical practice].
Perlaki G; Szekeres S; Janszky J; Dezső D; Aschermann Z; Zámbó K; Kovács N
Ideggyogy Sz; 2019 Nov; 72(11-12):381-388. PubMed ID: 31834681
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT.
Morgan S; Kemp P; Booij J; Costa DC; Padayachee S; Lee L; Barber C; Carter J; Walker Z
J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1063-70. PubMed ID: 22869921
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Sensitivity and Symptomatic Relevance of Dopamine Transporter Imaging and Myocardial Sympathetic Scintigraphy in Patients with Dementia with Lewy Bodies.
Tang Z; Hirano S; Koizumi Y; Izumi M; Kitayama Y; Yamagishi K; Tamura M; Ishikawa A; Kashiwado K; Iimori T; Mukai H; Yokota H; Horikoshi T; Uno T; Kuwabara S
J Alzheimers Dis; 2024; 100(1):127-137. PubMed ID: 38848178
[TBL] [Abstract][Full Text] [Related]
11. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
[TBL] [Abstract][Full Text] [Related]
12. Confirmation of
Maltais DD; Jordan LG; Min HK; Miyagawa T; Przybelski SA; Lesnick TG; Reichard RR; Dickson DW; Murray ME; Kantarci K; Boeve BF; Lowe VJ
J Nucl Med; 2020 Nov; 61(11):1628-1635. PubMed ID: 32198310
[TBL] [Abstract][Full Text] [Related]
13. The value of multimodal imaging with
Miyagawa T; Przybelski SA; Maltais D; Min HK; Jordan L; Lesnick TG; Chen Q; Graff-Radford J; Jones D; Savica R; Knopman D; Petersen R; Kremers WK; Forsberg LK; Fields JA; Ferman TJ; Allen L; Parisi J; Reichard RR; Murray M; Dickson D; Boeve BF; Kantarci K; Lowe VJ
Neurobiol Aging; 2021 Mar; 99():11-18. PubMed ID: 33422890
[TBL] [Abstract][Full Text] [Related]
14. [(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies.
van der Zande JJ; Booij J; Scheltens P; Raijmakers PG; Lemstra AW
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1060-6. PubMed ID: 26830298
[TBL] [Abstract][Full Text] [Related]
15. Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a
Pilotto A; Schiano di Cola F; Premi E; Grasso R; Turrone R; Gipponi S; Scalvini A; Cottini E; Paghera B; Garibotto V; Rizzetti MC; Bonanni L; Borroni B; Morbelli S; Nobili F; Guerra UP; Perani D; Padovani A
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1642-1651. PubMed ID: 31098748
[TBL] [Abstract][Full Text] [Related]
16. Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.
Roselli F; Pisciotta NM; Perneczky R; Pennelli M; Aniello MS; De Caro MF; Ferrannini E; Tartaglione B; Defazio G; Rubini G; Livrea P
Mov Disord; 2009 Oct; 24(14):2097-103. PubMed ID: 19705471
[TBL] [Abstract][Full Text] [Related]
17. Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies.
Taylor JP; Colloby SJ; McKeith IG; Burn DJ; Williams D; Patterson J; O'Brien JT
J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1069-71. PubMed ID: 17299017
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [
Chahid Y; Sheikh ZH; Mitropoulos M; Booij J
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):1974-1987. PubMed ID: 36847827
[TBL] [Abstract][Full Text] [Related]
19. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
[TBL] [Abstract][Full Text] [Related]
20. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.
Colloby SJ; Williams ED; Burn DJ; Lloyd JJ; McKeith IG; O'Brien JT
Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1176-85. PubMed ID: 15931516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
